SCHEMBL6509922

SCHEMBL6509922

CCCCC(C(=O)N1C(=O)CCC1=O)N1C(=O)C=CC1=O

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.33
PTGS2 P35354 3/20 0.33
MGLL Q99685 3/20 0.33
FAAH O00519 2/20 0.33
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.31
PKM P14618 1/20 0.31
PTPN1 P18031 1/20 0.30
ATM Q13315 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15252995 0.81 ALDH1A1 (0.40) PTGS1PTGS2KMT2ASMN1; SMN2ALDH1A1
SCHEMBL7443645 0.80 ALDH1A1 (0.38) ALDH1A1PKMPTPN1
SCHEMBL92947 0.79 CA2 (0.33) PTGS1PTGS2MGLLFAAHKMT2A
SCHEMBL43970 0.78 PTPN1 (0.42) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL12094816 0.78 MGLL (0.39) PTGS1PTGS2MGLLFAAHSMN1; SMN2
SCHEMBL15253083 0.77 KMT2A (0.40) PTGS1PTGS2KMT2ASMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL4277446 0.76 PTPN1 (0.41) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL2219783 0.76 CA2 (0.43) PTGS1PTGS2MGLLFAAHALDH1A1
SCHEMBL2034675 0.76 MGLL (0.38) PTGS1PTGS2MGLLFAAHSMN1; SMN2
SCHEMBL12275897 0.74 SMN1; SMN2 (0.36) PTGS1PTGS2MGLLFAAHKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936298-B2 Antithrombogenic membrane mimetic compositions and methods EMORY UNIVERSITY (US) 2005-08-30 US disclosed
US-20040073295-A1 Antithrombogenic membrane mimetic compositions and methods EMORY UNIVERSTIY 2004-04-15 US disclosed
US-6720161-B1 SUBSTRATE IS COVALENTLY BOUND TO A MONOMERIC OR OLIGOMERIC CONSTITUTIONAL UNIT OF A GEL AND THE RESULTANT PRODUCT IS POLYMERIZED. GESELLSCHAFT FUER BIOTECHNOLOGISCHE FORSCHUNG MBH (DE) 2004-04-13 US disclosed
EP-1272237-A1 ANTITHROMBOGENIC MEMBRANE MIMETIC COMPOSITIONS AND METHODS Emory University (US) 2003-01-08 EP disclosed
WO-2001078800-A1 ANTITHROMBOGENIC MEMBRANE MIMETIC COMPOSITIONS AND METHODS EMORY UNIVERSITY (US) 2001-10-25 WO disclosed